LAVA Therapeutics shares are trading higher after the company announced a $7 million payment because Pfizer achieved a clinical milestone for PF-08046052.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.